<code id='3BD2509E7A'></code><style id='3BD2509E7A'></style>
    • <acronym id='3BD2509E7A'></acronym>
      <center id='3BD2509E7A'><center id='3BD2509E7A'><tfoot id='3BD2509E7A'></tfoot></center><abbr id='3BD2509E7A'><dir id='3BD2509E7A'><tfoot id='3BD2509E7A'></tfoot><noframes id='3BD2509E7A'>

    • <optgroup id='3BD2509E7A'><strike id='3BD2509E7A'><sup id='3BD2509E7A'></sup></strike><code id='3BD2509E7A'></code></optgroup>
        1. <b id='3BD2509E7A'><label id='3BD2509E7A'><select id='3BD2509E7A'><dt id='3BD2509E7A'><span id='3BD2509E7A'></span></dt></select></label></b><u id='3BD2509E7A'></u>
          <i id='3BD2509E7A'><strike id='3BD2509E7A'><tt id='3BD2509E7A'><pre id='3BD2509E7A'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:486
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Report cites 'urgent' need to recruit more diverse clinical trial participants

          AdobeThepersistentlackofdiversityamongparticipantsinclinicaltrialsisacriticalissuethatisharmingbothp